Philip O. Livingston Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Philip O. Livingston.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Philip O. Livingston. Philip O. Livingston is Chief Science Officer in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Latest Insider Trading Transactions of Philip O. Livingston
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | |
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.96 | 3,571 | 3,428 | 256,554 | 260.1 K to 256.6 K (-1.37 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.98 | 12,301 | 12,055 | 260,125 | 272.4 K to 260.1 K (-4.52 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Sell | S | 0.96 | 21,155 | 20,309 | 272,426 | 293.6 K to 272.4 K (-7.21 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Buy | M | 0.00 | 100,000 | 0 | 293,581 | 193.6 K to 293.6 K (+51.66 %) |
Oct 04 2017 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 0.00 | 75,790 | 0 | 75,790 | |
Sep 18 2017 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 0.00 | 24,210 | 0 | 24,210 | |
May 23 2017 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 3.38 | 700 | 2,366 | 700 | |
Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 5.00 | 700 | 3,500 | 700 | |
Apr 07 2015 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | Chief Science Offic ... | Grant | A | 0.00 | 1,000,000 | 0 | 1,307,396 | 307.4 K to 1.3 M (+325.31 %) |
Page: 1